Antoine Desilets

8PUBLICATIONS
25CO-AUTHORS
Toxicology (incl. clinical toxicology)Medical molecular engineering of nucleic acids and proteinsProteins and peptidesNanotoxicology, health and safetyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Dec 05, 2025
Structure-Guided Optimization of Selective Covalent Reversible Peptidomimetic Inhibitors Targeting TMPRSS6.

Walid Guerrab, Matthieu Lepage, Antoine Désilets

|Mar 31, 2025
From N-0385 to N-0920: Unveiling a Host-Directed Protease Inhibitor with Picomolar Antiviral Efficacy against Prevalent SARS-CoV-2 Variants.

Gabriel Lemieux, Jimena Pérez-Vargas, Antoine Désilets

|Sep 11, 2024
Development of ketobenzothiazole-based peptidomimetic TMPRSS13 inhibitors with low nanomolar potency.

Alexandre Joushomme, Antoine Désilets, William Champagne

|Jul 19, 2024
Rational In Silico Design of Selective TMPRSS6 Peptidomimetic Inhibitors via Exploitation of the S2 Subpocket.

Michael Desgagné, Antoine Désilets, Sára Ferková

|Oct 21, 2023
Optimization of Ketobenzothiazole-Based Type II Transmembrane Serine Protease Inhibitors to Block H1N1 Influenza Virus Replication.

Éloïc Colombo, Antoine Désilets, Malihe Hassanzadeh

|Mar 28, 2022
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic.

Tirosh Shapira, I Abrrey Monreal, Sébastien P Dion

Pageof 2

Frequent Collaborators

6 joint publications

Pierre-Luc Boudreault

4 joint publications

Gabriel Lemieux

3 joint publications

Richard Leduc

2 joint publications

Michael Desgagné